counter argument please29 Jan 2019 12:35
So my current thinking is that this share is cheap, the Iran deal is simply not priced in, they are more or less EBITDA break-even (for a company where interest, depreciation and amortisation aren't particularly large) and have a new African contract that is apparently signed by WSG on the instruction of the client.
so what is the argument against a short term trade to buy now and expect it to go up on the Africa MOU or failing that Iran?
downsides that i see are that without a recurring $4.5m scanner deal equivalent then no longer break-even, the Iran deal falls through and the negative sentiment hits the share price (even though i don't think it's at all priced in) , or the Africa deal falls through - which seems odd given the client instruction to sign.
can someone please give me a valid reason not to top up please.
thanks in advance